We demonstrated that prophylactic use of the combination of a calcineurin inhibitor and IL-2 induces Treg expansion, and therapeutic use of this combination can maintain Treg proportions and ameliorate proteinuria in a murine model of SLE-like cGVHD. The gene discussed is IL2; the disease is systemic lupus erythematosus.